<?xml version="1.0" encoding="UTF-8"?>
<p>Ribavirin is an antiviral drug with a broad antiviral activity, initially used for treatment of HCV [
 <xref rid="B207-viruses-11-01017" ref-type="bibr">207</xref>]. It is a nucleic acid analog derived from guanosine and its main antiviral activity shown in vivo is its incorporation as a mutagenic nucleoside by the viral RNA polymerase [
 <xref rid="B208-viruses-11-01017" ref-type="bibr">208</xref>]. The use of ribavirin and immune serum globulin seems to decrease respiratory symptoms in MeV-infected patients [
 <xref rid="B209-viruses-11-01017" ref-type="bibr">209</xref>] but to date there is no standard protocol and doses recommended to treat patients.
</p>
